Valensa joins Algae Biomass Organization, eyes next gen microalgae nutraceuticals

© iStock/egal
© iStock/egal

Related tags Nutrition Health

Florida-based Valensa International has joined the Algae Biomass Organization (ABO), as the company recognizes algae as a source of sustainable and innovative nutraceuticals.

The Algae Biomass Organization (ABO) is a trade association for the algae industry that aims to create awareness about microalgae as a sustainable source of human nutrition, animal feed, water treatment services, chemicals, fuels, and countless other products.

“We are excited to have industry leader Valensa join the Algae Biomass Organization’s efforts to expand the availability of algae-based products in dozens of markets,”​ said Matt Carr, executive director of the Algae Biomass Organization.

“Valensa’s experience commercializing advanced technologies in human health and nutrition are among the most important for an industry that is just beginning show its potential to provide new products, improve global sustainability, and trigger new economic growth.”

Umasudhan, CEO and President, said Valensa is a “disruptive innovator” in microalgae-based nutraceuticals who creates sustainable indication-specific solutions for enhanced health.

“Valensa and affiliate Parry Nutraceuticals have been diligently working on expanding the scope of microalgae production technology including controlled race-way cultures, hybrid closed systems and fermentation technology needed to create safe, efficacious, microalgae-based nutraceuticals,” ​said Uma.

“Exclusive algae-based formulations will become the next generation of nutraceuticals to accommodate growing consumer demand for safe, healthy, sustainable-sourced, and all-natural products. We look forward to building the future of sustainable algae with the support of the ABO.”

Related news

Show more

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 22-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Effera™ Human Equivalent Lactoferrin

Effera™ Human Equivalent Lactoferrin

Content provided by Helaina Inc | 17-May-2024 | Product Brochure

Helaina’s bioactive protein Effera™ is a novel branded ingredient and the first clinically studied Human Lactoferrin on the market. Human Lactoferrin is...

Related suppliers

Follow us

Products

View more

Webinars